﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Wed, 06 May 2026 13:07:47 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/April-2022/rss/3177</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/April-2022/rss/3177" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Inpatient Insights]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/inpatient-insights-48</link><description><![CDATA[  APhA Staff  

 Approval stalled for tramadol I.V. 

   

 In an early February 2022 joint meeting, FDA’s Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management ...]]></description><pubDate>Mon, 07 Mar 2022 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/inpatient-insights-48</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3196]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[FDA warns about dental problems associated with buprenorphine medications]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/fda-warns-about-dental-problems-associated-with-buprenorphine-medications</link><description><![CDATA[  Hailey Mook, PharmD  

   

 In early January 2022, FDA released a Drug Safety Communication surrounding dental problems following use of buccal and sublingual buprenorphine products for the ...]]></description><pubDate>Mon, 07 Mar 2022 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/fda-warns-about-dental-problems-associated-with-buprenorphine-medications</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3193]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Acute illness may increase bleed risk among oral anticoagulant users]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/acute-illness-may-increase-bleed-risk-among-oral-anticoagulant-users</link><description><![CDATA[  Corey Diamond, PharmD  

   

 In the United States, oral anticoagulant use has increased by 54% since 2012, particularly with the use of newer direct oral anticoagulants (DOACs). ...]]></description><pubDate>Mon, 07 Mar 2022 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/acute-illness-may-increase-bleed-risk-among-oral-anticoagulant-users</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3194]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Excessive postoperative opioid use still an issue]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/excessive-postoperative-opioid-use-still-an-issue</link><description><![CDATA[  Maria G. Tanzi, PharmD  

   

 One in five patients continue to use opioids for longer than 3 months after a total hip or knee arthroplasty, according to results of a new analysis published in ...]]></description><pubDate>Mon, 07 Mar 2022 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/excessive-postoperative-opioid-use-still-an-issue</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3195]]></dc:identifier></item></channel></rss>